Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KDventures ABKDEVF 26 Net Cash per Share is $0.02 as of Mar. 2026, which is 100% below its 10-year median of 4.85. GuruFocus rates KDEVF with a GF Score™ of 26/100 and a GF Value™ of $0.68. The stock has 3 warning signs investors should review. Among 803 Biotechnology companies, KDventures AB ranks better than 84.93% on this metric.
The historical rank and industry rank for KDventures AB's Net Cash per Share or its related term are showing as below:
KDEVF'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.61 Med: 4.85 Max: 22.35
Current: 1.61
During the past 13 years, the highest Price-to-Net-Cash Ratio of KDventures AB was 22.35. The lowest was 1.61. And the median was 4.85.
KDEVF's Price-to-Net-Cash is ranked better than 84.93% of 803
companies
in the Biotechnology industry
Industry Median: 5.32
vs KDEVF: 1.61
KDventures AB (OTCPK:KDEVF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
KDventures AB Net Cash per Share Related Terms
KDventures AB Net Cash per Share Historical Data
* Premium members only.
The historical data trend for KDventures AB's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDEVF vs VRTX, REGN, ALNY: Net Cash per Share Comparison
For the Biotechnology subindustry, KDventures AB's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB Price-to-Net-Cash vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where KDventures AB's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
KDventures AB's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (KDEVF) has a Net Cash per Share of $0.02 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on KDventures AB and its competitors. This is 100% below median its historical median of 4.85. Over the past decade, KDventures AB's Net Cash per Share has ranged from 1.61 to 22.35. According to the industry distribution chart, KDventures AB ranks #121 out of 803 companies in the Biotechnology industry, placing it in the top 15.1%.
Is KDventures AB's Net Cash per Share too high?
KDventures AB's current Net Cash per Share of $0.02 is 100% below median its 10-year median of 4.85. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 22.35. The Biotechnology industry median Net Cash per Share is 5.32. KDventures AB's value of $0.02 is 99.6% below this industry median. Based on the distribution chart, KDventures AB ranks #121 out of 803 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, KDventures AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's Net Cash per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #121 out of 803 companies for Net Cash per Share. This places KDventures AB in the top 15% of its industry — outperforming the majority of peers. The industry median Net Cash per Share is 5.32. KDventures AB's value of $0.02 is 99.6% below this benchmark. Historically, KDventures AB's own Net Cash per Share has ranged from 1.61 to 22.35 over the past decade. While the company's 10-year median is 4.85 vs. the industry median of 5.32, KDventures AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Biotechnology company?
The median Net Cash per Share among Biotechnology companies is 5.32, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDventures AB's current Net Cash per Share of $0.02 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median Net Cash per Share is 5.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current Net Cash per Share is $0.02, which is 100% below median its own 10-year median of 4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current Net Cash per Share of $0.02. The stock's GF Value™ is $0.68, compared to a current price of $0.26 — trading 62.1% below its estimated fair value. The current Net Cash per Share is $0.02, which is 100% below median its 10-year median of 4.85 and 99.6% below the Biotechnology industry median of 5.32. KDventures AB's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For KDventures AB (KDEVF), the current Net Cash per Share is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 62.1% below its estimated GF Value™ of $0.68.
Key valuation signals for KDEVF:
Net Cash per Share: $0.02 (100% below median its 10-year median of 4.85)
GF Value™: $0.68 vs. price of $0.26 (62.1% below fair value)
Industry Position: 99.6% below the Biotechnology median (#121 of 803)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
26GF Score
Get the complete analysis for KDEVF
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
